Figure 2
Crude incidence of outcomes in warfarin and NOAC users by Kaplan–Meier analysis. NOAC non-vitamin K antagonist oral anticoagulant.
Figure 2 | Scientific Reports
Crude incidence of outcomes in warfarin and NOAC users by Kaplan–Meier analysis. NOAC non-vitamin K antagonist oral anticoagulant.
